121 related articles for article (PubMed ID: 36584330)
1. Promoter methylation levels of
Mashayekhi M; Asadi M; Hashemzadeh S; Vahedi A; Shanehbandi D; Al-Omar AF; Akbari M; Raeisi M
Horm Mol Biol Clin Investig; 2023 Jun; 44(2):145-152. PubMed ID: 36584330
[TBL] [Abstract][Full Text] [Related]
2. Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
Walter RFH; Rozynek P; Casjens S; Werner R; Mairinger FD; Speel EJM; Zur Hausen A; Meier S; Wohlschlaeger J; Theegarten D; Behrens T; Schmid KW; Brüning T; Johnen G
PLoS One; 2018; 13(5):e0195716. PubMed ID: 29851970
[TBL] [Abstract][Full Text] [Related]
3. Association of Promoter Methylation Patterns with Expression of MAPK14 in Tissue of Papillary Thyroid Cancer Patients.
Shahdust M; Zarredar H; Asadi M; Caner A; Dehghan M; Soleimani Z; Seyednejad F; Raeisi M
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3509-3515. PubMed ID: 37898857
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAF
Khatami F; Larijani B; Heshmat R; Nasiri S; Haddadi-Aghdam M; Teimoori-Toolabi L; Tavangar SM
J Cell Physiol; 2020 Oct; 235(10):6954-6968. PubMed ID: 32017063
[TBL] [Abstract][Full Text] [Related]
5. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J
Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445
[TBL] [Abstract][Full Text] [Related]
6. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
7. High-resolution melting-based quantitative analysis of RASSF1 methylation in breast cancer.
Stuopelytė K; Daniūnaitė K; Laurinavičienė A; Ostapenko V; Jarmalaitė S
Medicina (Kaunas); 2013; 49(2):78-83. PubMed ID: 23888343
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers.
Drilon A; Sugita H; Sima CS; Zauderer M; Rudin CM; Kris MG; Rusch VW; Azzoli CG
J Thorac Oncol; 2014 Sep; 9(9):1272-7. PubMed ID: 25122424
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of RASSF1 promoter methylation in prostate cancer.
Daniunaite K; Jarmalaite S; Kalinauskaite N; Petroska D; Laurinavicius A; Lazutka JR; Jankevicius F
J Urol; 2014 Dec; 192(6):1849-55. PubMed ID: 24980613
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methylation profiling in cancerous and their corresponding normal tissues from korean patients with breast cancer.
Jung EJ; Kim IS; Lee EY; Kang JE; Lee SM; Kim DC; Kim JY; Park ST
Ann Lab Med; 2013 Nov; 33(6):431-40. PubMed ID: 24205493
[TBL] [Abstract][Full Text] [Related]
11. Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma.
Khatami F; Larijani B; Heshmat R; Nasiri S; Saffar H; Shafiee G; Mossafa A; Tavangar SM
Iran J Pathol; 2019; 14(4):290-298. PubMed ID: 31754358
[TBL] [Abstract][Full Text] [Related]
12. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
13. [GSTP1, APC and RASSF1 gene methylation in prostate cancer samples: comparative analysis of MS-HRM method and Infinium HumanMethylation450 BeadChip beadchiparray diagnostic value].
Skorodumova LO; Babalyan KA; Sultanov R; Vasiliev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Generozov EV; Larin AK; Kostryukova ES; Sharova EI
Biomed Khim; 2016 Nov; 62(6):708-714. PubMed ID: 28026816
[TBL] [Abstract][Full Text] [Related]
14. EGFL7 and RASSF1 promoter hypermethylation in epithelial ovarian cancer.
Rattanapan Y; Korkiatsakul V; Kongruang A; Chareonsirisuthigul T; Rerkamnuaychoke B; Wongkularb A; Wilailak S
Cancer Genet; 2018 Aug; 224-225():37-40. PubMed ID: 29778234
[TBL] [Abstract][Full Text] [Related]
15. The Role of RASSF1 Methylation in Lung Carcinoma.
Zhang T; Li Y; Zhang H; Wang X; Liu X; Li L
Adv Exp Med Biol; 2020; 1255():99-108. PubMed ID: 32949393
[TBL] [Abstract][Full Text] [Related]
16. MS-FLAG, a novel real-time signal generation method for methylation-specific PCR.
Bonanno C; Shehi E; Adlerstein D; Makrigiorgos GM
Clin Chem; 2007 Dec; 53(12):2119-27. PubMed ID: 17962364
[TBL] [Abstract][Full Text] [Related]
17. MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?
Yamashita S; Yokogami K; Matsumoto F; Saito K; Mizuguchi A; Ohta H; Takeshima H
J Neurosurg; 2018 May; 130(3):780-788. PubMed ID: 29726772
[TBL] [Abstract][Full Text] [Related]
18. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
19. Danhong Injection Alleviates Cardiac Fibrosis via Preventing the Hypermethylation of Rasal1 and Rassf1 in TAC Mice.
Li S; Li P; Liu W; Shang J; Qiu S; Li X; Liu W; Shi H; Zhou M; Liu H
Oxid Med Cell Longev; 2020; 2020():3158108. PubMed ID: 33456666
[TBL] [Abstract][Full Text] [Related]
20. Gene promoter methylation and cancer: An umbrella review.
Bouras E; Karakioulaki M; Bougioukas KI; Aivaliotis M; Tzimagiorgis G; Chourdakis M
Gene; 2019 Aug; 710():333-340. PubMed ID: 31202904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
